Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations
JCO Oncology Practice · 2024
DOI: 10.1200/op.23.00574 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2024. Verfasst von Rachel A Rodenbach und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Wisconsin Carbone Cancer Center, Madison, WI. Hauptthemen laut MEDLINE: Communication, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
PURPOSE Shared decision making (SDM) is essential to empower patients with blood cancers to make goal-concordant decisions about allogeneic hematopoietic cell transplantation. This study characterizes communication strategies used by hematologists to discuss treatment options and facilitate SDM with patients in this high-risk, high-reward setting. METHODS AND MATERIALS We recruited US hematologists who routinely perform allogeneic hematopoietic cell transplant through email. Participants conducted up to an hour-long video-recorded encounter with an actor portraying a 67-year-old man with recently diagnosed high-risk myelodysplastic syndrome. We transcribed and qualitatively analyzed video-recorded data. RESULTS The mean age of participants (N = 37) was 44 years, 65% male, and 68% White. Many hematologists included similar key points in this initial consultation, although varied in how much detail they provided. Their discussion of treatment options included transplant and chemotherapy and less commonly supportive care or clinical trials. They often emphasized transplant's potential for cure, discussed transplant chronologically from pretransplant considerations through the post-transplant course, and outlined risks, complications, and major outcomes. Hematologists referred to several elements that formed the basis of treatment decision making. The strength of their treatment recommendations ranged from strong recommendations for transplant or chemotherapy to deferrals pending more information. Hematologists also varied in the extent to which they indicated the decision was physician-driven, patient-led, or shared. CONCLUSION The transplant decision-making discussion is complex. Identification of similar content areas used by hematologists can be used as the basis for a communication tool to help hematologists discuss allogeneic hematopoietic cell transplant with patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Wisconsin Carbone Cancer Center, Madison, WI.
- James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.
- University of Wisconsin Department of Psychology, Madison, WI.
- Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI.
- Icahn School of Medicine at Mount Sinai, New York, NY.
ORCID-Profile: Rachel A Rodenbach, Markus Brauer, Aric C Hall, Cardinale B Smith, Toby C Campbell
Förderung
- NHLBI NIH HHS
Zitieren
APA
Rodenbach, R. A., Thordardottir, T., Brauer, M., Hall, A. C., Ward, E., Smith, C. B., & Campbell, T. C. (2024). Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations. JCO Oncology Practice. https://doi.org/10.1200/op.23.00574
Vancouver
Rodenbach RA, Thordardottir T, Brauer M, Hall AC, Ward E, Smith CB, et al. Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations. JCO Oncology Practice. 2024. doi:10.1200/op.23.00574
BibTeX
@article{Rodenbach2024,
author = {Rodenbach, Rachel A and Thordardottir, Thorunn and Brauer, Markus and Hall, Aric C and Ward, Earlise and Smith, Cardinale B and Campbell, Toby C},
title = {Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations},
journal = {JCO Oncology Practice},
year = {2024},
doi = {10.1200/op.23.00574}
}
EUVIMED